Cargando…
Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection
Progressive dopaminergic neurodegeneration is responsible for the canonical motor deficits in Parkinson's disease (PD). The widely prescribed anti-diabetic medicine metformin is effective in preventing neurodegeneration in animal models; however, despite the significant potential of metformin f...
Autores principales: | Kang, Hojin, Khang, Rin, Ham, Sangwoo, Jeong, Ga Ram, Kim, Hyojung, Jo, Minkyung, Lee, Byoung Dae, Lee, Yun Il, Jo, Areum, Park, ChiHu, Kim, Hyein, Seo, Jeongkon, Paek, Sun Ha, Lee, Yun-Song, Choi, Jeong-Yun, Lee, Yunjong, Shin, Joo-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564711/ https://www.ncbi.nlm.nih.gov/pubmed/28611284 http://dx.doi.org/10.18632/oncotarget.18122 |
Ejemplares similares
-
Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model
por: Ham, Sangwoo, et al.
Publicado: (2017) -
CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation
por: Kim, Hyojung, et al.
Publicado: (2017) -
Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015) -
Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s Disease
por: Ham, Sangwoo, et al.
Publicado: (2019) -
Loss of zinc-finger protein 212 leads to Purkinje cell death and locomotive abnormalities with phospholipase D3 downregulation
por: Khang, Rin, et al.
Publicado: (2021)